Neoadjuvant chemotherapy in locally advanced nasopharyngeal carcinoma: Defining high-risk patients who may benefit before concurrent chemotherapy combined with intensity-modulated radiotherapy.
about
Pretreatment hematologic markers as prognostic factors in patients with nasopharyngeal carcinoma: A systematic review and meta-analysis.Prognostic Value of Neoadjuvant Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma with Low Pre-treatment Epstein-Barr Virus DNA: a Propensity-matched Analysis.Revalidation of a prognostic score model based on complete blood count for nasopharyngeal carcinoma through a prospective study.An inflammatory biomarker-based nomogram to predict prognosis of patients with nasopharyngeal carcinoma: an analysis of a prospective study.Significant survival benefit of adjuvant chemotherapy after concurrent chemoradiotherapy in locally advanced high-risk nasopharyngeal carcinoma.A Rare Presentation of Primary Nasopharyngeal Carcinoma (NPC) in Mediastinum.Decreased Overall and Cancer-Specific Mortality with Neoadjuvant Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma Treated by Intensity-modulated Radiotherapy: Multivariate Competing Risk Analysis.Prognostic value of chemotherapy in addition to concurrent chemoradiotherapy in T3-4N0-1 nasopharyngeal carcinoma: a propensity score matching study.The predictive value of pre- and post-induction chemotherapy plasma EBV DNA level and tumor volume for the radiosensitivity of locally advanced nasopharyngeal carcinoma.Cycle number of neoadjuvant chemotherapy might influence survival of patients with T1-4N2-3M0 nasopharyngeal carcinoma.The current status of clinical trials focusing on nasopharyngeal carcinoma: A comprehensive analysis of ClinicalTrials.gov database.
P2860
Q30235263-E236311F-8715-4D96-9E70-17C60F1D8059Q37133656-AAA9085A-23FB-44E6-8B50-A06C257D71C6Q37402090-3DAA5773-1AA0-40A7-BBF0-C4C5283BA3A6Q37609486-A5195CC0-B358-4005-AAD8-B50ABB08CDBFQ37620559-DE7F1BD9-6330-46CC-B768-8505D5CEB86DQ40530241-3BCA5C28-25D1-4D9A-A037-0F35201D5B59Q41242545-DD3E0D93-3C60-4EAB-8087-AF1622F0B6C5Q46721131-6CBC0AE0-2ED7-4203-83C0-031A65A71EC3Q47553783-5405984C-43D2-4AE3-9A7E-1DF858A81945Q52653167-1EE15B5F-46D7-4C97-943B-F0E60DE558A0Q54965220-705CFC28-AB2B-44FF-8952-AD1DC6996D2C
P2860
Neoadjuvant chemotherapy in locally advanced nasopharyngeal carcinoma: Defining high-risk patients who may benefit before concurrent chemotherapy combined with intensity-modulated radiotherapy.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Neoadjuvant chemotherapy in lo ...... ensity-modulated radiotherapy.
@ast
Neoadjuvant chemotherapy in lo ...... ensity-modulated radiotherapy.
@en
type
label
Neoadjuvant chemotherapy in lo ...... ensity-modulated radiotherapy.
@ast
Neoadjuvant chemotherapy in lo ...... ensity-modulated radiotherapy.
@en
prefLabel
Neoadjuvant chemotherapy in lo ...... ensity-modulated radiotherapy.
@ast
Neoadjuvant chemotherapy in lo ...... ensity-modulated radiotherapy.
@en
P2093
P2860
P356
P1433
P1476
Neoadjuvant chemotherapy in lo ...... ensity-modulated radiotherapy.
@en
P2093
Ai-Hua Lin
Jian-Yong Shao
Mu-Sheng Zeng
Tie-Bang Kang
Xiao-Jing Du
Yan-Ping Mao
P2860
P2888
P356
10.1038/SREP16664
P407
P577
2015-11-13T00:00:00Z
P5875
P6179
1017834189